| 2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
| 2023 | Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study
| CANCERS |
| 2021 | Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
| 2017 | Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2016 | Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease. | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
| 2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis | HEPATOLOGY |
| 2021 | Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
| GUT AND LIVER |
| 2014 | Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2019 | Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2014 | Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma. | LIVER INTERNATIONAL |
| 2015 | Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization | DIGESTIVE AND LIVER DISEASE |
| 2019 | Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study
| KOREAN JOURNAL OF RADIOLOGY |
| 2023 | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria
| CANCER RESEARCH AND TREATMENT |
| 2013 | Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
| PLOS ONE |
| 2016 | Knockdown of HIF-1a and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells | APOPTOSIS |
| 2010 | Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
| 2012 | Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir. | LIVER INTERNATIONAL |
| 2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2017 | Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection. | ONCOLOGY |
| 2019 | Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
| GUT AND LIVER |
| 2017 | Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke | ATHEROSCLEROSIS |
| 2019 | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | CEREBROVASCULAR DISEASES |
| 2009 | Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2012 | Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. | DIGESTIVE DISEASES AND SCIENCES |
| 2009 | Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis | LIVER INTERNATIONAL |
| 2014 | Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
| PLOS ONE |
| 2015 | Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis | LIVER INTERNATIONAL |
| 2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
| 2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
| 2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
| 2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
| ANTIVIRAL THERAPY |
| 2014 | Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir | LIVER INTERNATIONAL |
| 2005 | Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2022 | Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
| 2014 | Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study | JOURNAL OF VIRAL HEPATITIS |
| 2019 | Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
| 2015 | Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin | DIGESTIVE DISEASES AND SCIENCES |
| 2022 | Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects | LIVER INTERNATIONAL |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2014 | Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. | LIVER INTERNATIONAL |
| 2008 | MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
| CARCINOGENESIS |
| 2021 | Measuring radiation exposure of operators engaged in the yttrium-90 microsphere radioembolization treatment of hepatocellular carcinoma patients | OPTIK |
| 2011 | MELD-based indices as predictors of mortality in chronic liver disease patients who undergo emergency surgery with general anesthesia | JOURNAL OF GASTROINTESTINAL SURGERY |
| 2021 | Metabolic activity assessment by 18 F-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2019 | Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
| GUT AND LIVER |
| 2008 | Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
| 2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2010 | New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification
| JOURNAL OF CLINICAL MICROBIOLOGY |
| 2021 | No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2010 | Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression
| HEPATOLOGY INTERNATIONAL |
